Skip to main content
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
letter
. 2006 May;88(3):336. doi: 10.1308/003588406X106360

Intervention to Decompress the Upper Tracts in Patients with Established Pelvic Malignancies

Tim Lane 1, John Hines 1
PMCID: PMC1963695  PMID: 16720009

Intervention to decompress the upper tracts in patients with established pelvic malignancies is fraught with both technical and ethical difficulties. Two issues have become increasingly clear in the management of such cases – neither of which is particularly clear from the article. First, for decompression, percutaneous procedures are preferable to attempts at retrograde stenting. Chitale and co-workers,1 for example, compared the relative success rates and reported a 21% success rate with retrograde stenting and a 100% success rate with nephrostomies. Additionally, it would appear that even if retrograde stenting is successful, there is considerable doubt over the efficacy of the ureteral stents given that intra-uretral stent placement alone has only a marginal effect on improving renal function. It would seem that there is a complex interplay between ureteral peristalsis, venting stent sideholes and flow rate. At the most basic level, failure of ureteral co-aptation prevents extraluminal urine flow so that intraluminal stent flow becomes increasingly important – a factor often compromised in extrinsic compression.2 Second, the selection of patients who might benefit from intervention is less disease specific (as the authors intimate) and instead better related to available treatment options.3 In the study by Watkinson et al.,3 the authors reviewed 50 patients with advanced abdomino-pelvic malignancies who underwent percutaneous nephrostomy. Four groups were sub-classified by median survival times. In that group with relapsed disease for which there was no conventional treatment option, the median survival time was extremely poor (median, 38 days) with no long-term survivors – poorer outcomes than any described by Wilson et al. Intervention in this group of patients necessarily needs to be individualised and considered on a case-by-case basis by a multidisciplinary team. Only then can patients make an informed judgement about the merits of intervention.

Footnotes

References

  • 1.Chitale SV, Scott-Barrett S, Ho ETS, Burgess NA. The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol. 2002;57:1118–21. doi: 10.1053/crad.2002.1114. [DOI] [PubMed] [Google Scholar]
  • 2.Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: experience in two institutions. J Urol. 1989;142:277–9. doi: 10.1016/s0022-5347(17)38729-3. [DOI] [PubMed] [Google Scholar]
  • 3.Watkinson AF, A'Hern RP, Jones A, King DM, Moskovic EC. The role of percutaneous nephrostomy in malignant urinary obstruction. Clin Radiol. 1993;47:32–5. doi: 10.1016/s0009-9260(05)81210-3. [DOI] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES